Showing 22,691 results

Filters Content type: Editors' picks
Hepatitis C treatment

Doctor Panel to Weigh Hepatitis C Drugs’ Costs in Guidelines

Editor's pick
Bloomberg
2 March 2015
The search for a cure

Doctor who cured ‘Berlin patient’ of HIV: ‘We knew we were doing something very special’

Editor's pick
Fred Hutch News
2 March 2015
Retention & linkage to care

New York City Gets Its HIV Act Together

Editor's pick
MedPage Today HIV/AIDS
2 March 2015
Epidemiology & behaviour

The varied nature of the US HIV/AIDS epidemic: what makes the South so different?

Editor's pick
BMJ Group blogs
2 March 2015
PrEP

PrEP: So Effective, It's Unheard Of

Editor's pick
The Body.com
27 February 2015
Sex workers

HIV stigma drives sex work in Northern Kenya

Editor's pick
Key Correspondents
27 February 2015
PrEP

UNAIDS welcomes further evidence of the efficacy of antiretroviral medicines in preventing new HIV infections

Editor's pick
UNAIDS
27 February 2015
Starting treatment

Inflammation Persists Despite Very Early HIV Treatment

Editor's pick
The Body Pro
27 February 2015
Pharmaceutical industry

Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Editor's pick
Chicago Tribune
27 February 2015
HIV prevention policy

HIV Prevention Cuts Medical Costs

Editor's pick
MedPage Today HIV/AIDS
27 February 2015
PrEP

HIV pill: The logic of paying £500 a month so gay men don't have to wear condoms

Editor's pick
The Independent
26 February 2015
TB treatment

CROI 2015: Trial to evaluate the use of health navigators to link HIV/TB patients to care and treatment fails to show positive results

Editor's pick
Science Speaks
26 February 2015
Hepatitis C treatment

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Editor's pick
NICE press release
26 February 2015
New & experimental hepatitis C treatment

New hepatitis C treatments highly effective for HIV/HCV coinfected people

Editor's pick
HIVandHepatitis.com
26 February 2015
New & experimental HIV treatments

48-week analysis of investigational HIV-1 attachment inhibitor paves way for Phase III trial initiation

Editor's pick
Bristol Myers Squibb press release
26 February 2015
Hepatitis C transmission & prevention

Sexual Transmission of HCV in Gay Men Should Not Be a PrEP Deterrent, Say Advocates

Editor's pick
The Body
26 February 2015
Behaviour change interventions

What We Know About HIV Transmission Should Influence PrEP Messaging

Editor's pick
The Body
26 February 2015
Harm reduction

Auto-Disable Syringes Are Not For Needle Programmes

Editor's pick
National Needle Exchange Forum
26 February 2015
PrEP

HIV treatment finally has a game-changer, and it’s called Truvada

Editor's pick
The Guardian
26 February 2015
PrEP

CDC Statement on IPERGAY Trial of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention among Men Who Have Sex with Men

Editor's pick
CDC (US)
25 February 2015
PrEP

HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

Editor's pick
EATG
25 February 2015
PrEP

'Give HIV drugs to healthy gay men'

Editor's pick
BBC News
25 February 2015
Access to healthcare

Merck places children's HIV drug in shared non-profit patent pool

Editor's pick
Reuters
24 February 2015
PrEP

Human Rights Campaign Launches #DailyBlue Campaign Combating PrEP-Related Stigma

Editor's pick
Human Rights Campaign
24 February 2015